Alnylam picks Jacobs to help construct $200m RNAi manufacturing plant in MA
Alnylam’s RNAi manufacturing plant will be operational by 2018 and the firm says it is willing to invest in a second facility depending on its pipeline success.
Archives for August 7, 2016
Teva sees API sales surge in Q2
Teva Pharmaceutical Industries has reported higher second quarter API revenue citing a surge in demand from customers in the US and Europe.
Bangladesh Court orders 34 drug firms to halt production, again
The High Court in Bangladesh has ordered 34 firms to stop making drugs and recall products after discovering they had ignored a ban imposed in June.
CRO earnings report roundup
Over the past several weeks, the CRO industry has released its financial results – and there is no indication of slowdown, says analyst.
WR Grace opens pharma-focused QC lab and predicts second half intemediates growth
W.R. Grace has opened a pharma quality control laboratory at its manufacturing facility in Albany, Oregon and predicted higher drug intermediates sales in the second half of the year.
US Senator calls for clinical trial data sharing, consortium responds
US Senator Elizabeth Warren recently published a perspective calling for strengthening research through data sharing – but the perspective was not met without feedback.
Almac Group services support first commercial orphan drug products
Almac Group has announced that two of its clients have recently received approvals of their first orphan drug product.
Third strike for Wockhardt as API facility hit with US import alert
The US FDA has banned products from a third Indian manufacturing plant operated by Wockhardt.